Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 3 Apr 24 POSASR Automatic shelf registration (post-effective amendment)
- 27 Apr 22 EFFECT Notice of effectiveness
- 28 Mar 22 POS AM Prospectus update (post-effective amendment)
-
28 Mar 22 POSASR Automatic shelf registration (post-effective amendment)
- 3 Jan 22 S-3ASR Automatic shelf registration
KNTE similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 29, 2021, with respect to the financial statements of Kinnate Biopharma Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
March 28, 2022